<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03916445</url>
  </required_header>
  <id_info>
    <org_study_id>2019-00366</org_study_id>
    <nct_id>NCT03916445</nct_id>
  </id_info>
  <brief_title>Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases</brief_title>
  <official_title>Resilience and Quality of Life in Patients With Gynaecological Carcinomas and Chronic Gynaecological Diseases: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intended pilot project aims at evaluating the feasibility and acceptability of
      questionnaires about resilience and quality of life in two different patient groups (either
      with a gynaecological carcinoma ora chronic gynaecological disease). The results provided by
      this pilot study will build the basis of an upcoming, larger project including these
      questionnaires and the main objective of assessing resilience. More precisely, the study aims
      at answering the following questions. How is the overall resilience and quality of life in
      the target population at one assessment point? Are the instruments used in this pilot
      feasible for the target population when assessing resilience and quality of life?
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 28, 2019</start_date>
  <completion_date type="Actual">April 26, 2019</completion_date>
  <primary_completion_date type="Actual">April 26, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>resilience measured by questionnaire</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Total Score of the resilience questions is 0 to 40, 10 subscales from 0 to 4 (summed up for total score), the higher the score the better the resilience</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life measured by questionnaire</measure>
    <time_frame>up to 1 year</time_frame>
    <description>Questions about Quality of life: Total score 0-25, 5 subscales 0 to 5 (summed up for total score), the higher the score the lower is Quality of life.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>quality of life measured by VAS in the questionnaire</measure>
    <time_frame>up to 1 year</time_frame>
    <description>visual analogue scale (VAS) about Feeling healthy: Score 0 to 100 the higher the score the better is Quality of life</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">132</enrollment>
  <condition>Gynecologic Disease</condition>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>gynecological cancer</arm_group_label>
    <description>all patients having a consultation doctor during the recruiting time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>chronic gynecological disease</arm_group_label>
    <description>all patients having a consultation doctor during the recruiting time</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Connor Davidson Resilience Scale (CD-RISC 10)</intervention_name>
    <description>questionnaires about resilience (Connor Davidson Resilience Scale(CD-RISC 10)) and quality of life (EQ-5D-5L)</description>
    <arm_group_label>chronic gynecological disease</arm_group_label>
    <arm_group_label>gynecological cancer</arm_group_label>
    <other_name>EQ-5D-5L</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        female patients with a chronic gynecological disease or a gynaecological carcinoma,
        currently treated at the hospital
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female,

          -  &gt;18 years old,

          -  german speaking

        exclusion criteria:

        - insufficient study language skills
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Viola Heinzelmann-Schwarz, Prof. Dr. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universit√§tsspital Frauenklinik</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genital Diseases, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

